How long did patients stay on the Juniper programme and why did they stop?

Key takeaways

• Juniper UK patients stayed on the programme, on average, for 183 days.
• The most common reason for discontinuing was the cost of the programme, followed by dissatisfaction with the results and intolerable side effects.

Juniper’s adherence rate

Previous real-world research suggested that patients on Juniper’s platform were more likely to lose weight than clinical trials using the same medication.

However, to gain a more accurate understanding of how effective Juniper’s digital weight loss programme really is, it’s important to understand how long patients remained on it, and why they discontinued treatment.

A dedicated adherence study published in the Journal of Community Medicine & Public Health indicated that patients stayed on the Juniper programme, on average, for 6 months (183 days). The two most common reasons for discontinuing the programme were programme cost (38.7%) and dissatisfaction with results (16.8%).

Data was taken from self-directed, non-incentivised patients. Unlike clinical trials, in which participants don’t have to pay for treatment, this was a real-world study.

Understanding patient adherence

• This is the first peer-reviewed study to measure the adherence rate of a UK digital weight loss service
• The Juniper programme is designed to give patients the tools they need to succeed, however, adherence to our recommended programme is not mandatory
• This study was entirely comprised of self-directed, non-incentivised patients
• As stock availability of these treatments improves, patient adherence to Juniper’s comprehensive, multidisciplinary programme should improve

Key reasons for discontinuation

• Programme cost (38.7%)
• Dissatisfaction with results (16.8%)
• Intolerable side effects (15.4%)
• Goal achieved (7.3%)
• Temporary hiatus/going on holiday (5.6%)

Why we did this research

In order to continue improving our programme, we wanted to better understand exactly how long the average patient stayed on Juniper’s programme and what barriers they experienced to continuing treatment.

We’re committed to transparently publishing our data so that we can continue to improve our programme.